OUR MISSION
At Taiho Oncology our mission is to improve the lives of patients with cancer, their families, and their caregivers.
![Couple Outdoors](https://taiho-europe-website.s3.eu-central-1.amazonaws.com/images/about-us-default.original.original.png)
WHO WE ARE
![Team standing on platform](https://taiho-europe-website.s3.eu-central-1.amazonaws.com/images/who-we-are.original.original.jpg)
Taiho Oncology Europe GmbH (Baar, Switzerland) is the European subsidiary of Taiho Pharmaceutical Co., Ltd. (Tokyo, Japan). It is a clinical development and commercial base for pharmaceutical business in Europe.
Together with Taiho Pharmaceutical, Taiho Oncology, Inc. (New Jersey, US), a subsidiary of Taiho Pharmaceutical, supports its operation in Europe.
Taiho Oncology Europe was established in 2020.
Taiho Oncology Europe is an indirect subsidiary of Otsuka Holdings Co., Ltd., which contains more than 190 companies, with over 47,000 employees, in over 30 countries worldwide. The Otsuka Group of companies, whose origins date back to 1921, aims to contribute to the health of people around the world.
BACKED BY A STRONG HERITAGE
![Taiho Oncology Europe](https://taiho-europe-website.s3.eu-central-1.amazonaws.com/images/taiho_europe_text_short.original.original.png)
Taiho Oncology Europe, GmbH has a pipeline consisting of selectively-targeted anti-cancer agents that can be taken orally.
Established in 2020, in Zug, Switzerland, as a subsidiary of Taiho Pharmaceutical Co., Ltd. and Otsuka Holdings Co., Ltd.
![Taiho Pharmaceutical Co., Ltd. Logo](https://taiho-europe-website.s3.eu-central-1.amazonaws.com/images/taiho-corporate-logo_B4fhRch.original.original.png)
A specialty pharma company, focusing on drug discovery, preclinical research, clinical development, and building a network comprising of production, marketing, research & development in the fields of oncology, allergy and immunology, and urology.
In the company’s primary field of oncology, Taiho Pharmaceutical carries out global development of its mainstay anti-cancer agents in Japan, the US, Europe, and Asia.
The company also offers consumer health care products including nutritive energy drinks and herbal digestive support drinks.
Established in 1963, in Japan.
For more information, visit www.otsuka.com/en
OUR IDENTITY
![Taiho Symbol](https://taiho-europe-website.s3.eu-central-1.amazonaws.com/images/taiho-symbol.original.original.png)
THE SYMBOL
Our corporate identity was designed to reflect the organization’s guiding principles and to inspire feelings of natural energy, vitality, youth, and vigor.
The main concept of the Taiho Oncology logo is that of vital energy, with an emphasis on the energy produced by Mother Nature. This refers to the natural energy that puts forth a tree, which then grows a robust trunk, extends a branch, makes a flower bloom, and then bears fruit. The logo also captures the harmony between earth and the sun—the source of all growth and vitality on earth. This is a symbol of vitality from ancient times.
The “T” represents the initial letter of Taiho, and the power of nature is expressed by the fact that the logo is hand-drawn.
THE COLORS
Red is used to portray our company’s energy, vitality, and liveliness. The sepia (brown), an ecological color, represents human beings on earth and the intention of natural symbiosis. The yellow conveys that this is a new company, overflowing with youth and vigor.